AMRI to Announce Third Quarter Results
ALBANY, N.Y., Oct. 30, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue third quarter financial results before the opening of the market on Tuesday, November 6, 2012. Following the release of its results, the company will host a conference call and simultaneous webcast at 10 a.m. ET.
The conference call can be accessed by dialing 888-364-3108 (domestic calls) or 719-457-2645 (international calls) at 9:45 a.m. ET and entering passcode 8248928. The webcast will be available live via the Internet and can be accessed on the company's website at www.amriglobal.com. Replays of the webcast can also be accessed for up to 90 days after the call via the investor area of the company's website at www.amriglobal.com/investor_relations/.
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.
More by this Source
AMRI Burlington Receives DEA Approval to Handle Controlled Substances
Jun 18, 2013, 08:00 ET
AMRI Promotes Susan Collins to Director, Business Development
Jun 17, 2013, 08:00 ET
AMRI CEO to Present at the 2013 Wells Fargo Securities Healthcare Conference
Jun 12, 2013, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.